Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-22T13:45:16.788Z Has data issue: false hasContentIssue false
  • English
  • Français

Changes in Urine Volume and Diurnal Rhythm caused by Reserpine Treatment of Schizophrenic Patients

Published online by Cambridge University Press:  29 January 2018

Axel Randrup  and
Ib Munkvad
Axel Randrup
Affiliation:
St. Hans Hospital, Department E., Roskilde, Denmark
Ib Munkvad
Affiliation:
St. Hans Hospital, Department E., Roskilde, Denmark
Get access Rights & Permissions [Opens in a new window]

Extract

During a study of schizophrenic patients under prolonged treatment with reserpine alternating with placebo, night and day portions of urine were sampled for the determination of 4.-hydroxy-3-methoxymandelic acid (VMA). We found that reserpine treatment caused a moderate decrease in the excretion of this metabolite of adrenaline and noradrenaline, as reported in detail elsewhere (Munkvad and Randrup). We also observed certain characteristic changes in urine volume and diurnal rhythm, and these changes will be reported on in the present paper.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 112 , Issue 483 , February 1966 , pp. 173 - 176
Copyright
Copyright © Royal College of Psychiatrists, 1966 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Andersen, E., Kemp, A., Kirkegaard, Aa., Kirkegaard, G., Klinken-Rasmussen, T., Lyager, T., Nielsen, J. B., Olsen, H., Rokkjaer, E., Rontorp, P. S., and Schulsinger, F. (1957). “Clinical experiences with serpasil treatment in a mental hospital.” Acta psychiat. neurol. Scand., 32 (suppl.), 117, 7–82.Google Scholar
Barsa, J., and Kline, N. (1955). “Treatment of two hundred disturbed psychotics with reserpine.” J. Amer. med. Ass., 158, 110–113.Google Scholar
Chaudhury, R. R., Chaudhury, M. R., and Lu, F. C. (1962). “The mechanism of the reserpine-induced antidiuresis in the rat.” Canad. J. Biochem. Physiol., 40, 1465–1472.CrossRefGoogle ScholarPubMed
Gaddum, J., Krtvoy, W., and Laverty, G. (1958). “The action of reserpine on the excretion of adrenaline and noradrenaline.” J. Neurochem., 2, 249–253.Google Scholar
Gjessing, R. (1936). “Beiträge zur Kenntnis der Pathophysiologic der katatonen Erregung.” Arch. Psychiat. Nervenkr., 104, 355–416.CrossRefGoogle Scholar
Goldman, D. (1956). “The major complications of treatment of psychotic states with chlorpromazine and reserpine.” Psychiat. Res. Rep., 4, 79–88.Google Scholar
Hoskins, R. (1946). The Biology of Schizophrenia. New York.Google Scholar
Huchteman, K., and Pflugfelder, G. (1955). “Serpasilkuren in der Psychiatrie (Bericht über 100 Kuren).” Schweiz. med. Wschr., 85, 627–630.Google Scholar
Khazan, N., Adir, J., Pfeifer, Y., and Sulman, F. (1962). “Mechanism of the antidiuretic action of reserpine.” Proc. Soc. exp. Biol. med., 109, 32–35.Google Scholar
Liebaldt, G. (1958). “Reserpintodesfälle?” Nervenarzt., 29, 110–116.Google Scholar
Marley, E., and Pare, C. (1956). “Cardiac failure with reserpine.” Brit. med. J., 1, 267–269.Google Scholar
Melick, R., and McGregor, M. (1957). “Reserpine and extracellular fluid volume.” New Engl. J. Med., 256, 1000–1002.CrossRefGoogle ScholarPubMed
Miner, R. W. (1955). “Reserpine in the treatment of neuropsychiatric, neurological, and related clinical problems.” Arm. N.Y. Acad. Sci., 61, 1–280.Google Scholar
Munkvad, I., and Randrup, A. (1965). “Urinary excretion of 4-hydroxy-3-methoxymandelic acid in psychotic patients during treatment with reserpine and chlorpromazine,” in Neuropsychopharmacology, vol. 4 (ed. Bradley, . Amsterdam: Elsevier. In press.Google Scholar
Randrup, A. (1962). “Determination of urinary 3-methoxy-4-hydroxymandelic (vanilmandelic) acid by electrophoresis at low pH.” Scand. J. clin. lab. Invest.,Google Scholar
Wing, L. (1956). “The use of reserpine in chronic psychotic patients: a controlled trial.” J. ment. Sci., 102, 530–541.Google Scholar
Wodraska, T. W., Saunders, J. C., and Kline, N. S. (1958). “Combined ritalin and serpasil therapy in chronic psychoses.” Dis. nerv. Syst., 29, 3.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.